BioCatalyst

Omicron Subvariant-Based SARS-CoV-2 Recombinant Spike Vaccine Adjuvanted With Matrix-M — catalyst calendar

1 verified catalyst event(s) referencing Omicron Subvariant-Based SARS-CoV-2 Recombinant Spike Vaccine Adjuvanted With Matrix-M, each linked to its official source. Verified as of 2026-10-16.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-26
in 1mo
ESTIMATED
 READOUT
Study of a Recombinant Spike COVID-19 Vaccine With Matrix-M in Older Adults and
Phase 4 · COVID-19
 SNY Sanofi Omicron Subvariant-Based SARS-CoV-2 Reco ClinicalTrials.gov ↗
✓ Source-checked 2026-10-16
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.